FDA
approval
· 2022-06-22
FDA Approved: SUMATRIPTAN — Supplemental Application (Aurobindo Pharma Limited)
Summary
FDA approved a supplemental application for Sumatriptan succinate by Aurobindo Pharma Limited, updating an existing Sumatriptan product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SUMATRIPTAN (SUMATRIPTAN SUCCINATE)